NCT05683262

Brief Summary

Coccydynia refers to a significant pain, that does not radiate, in and around the coccyx region. This symptom is typically worsen while sitting, especially on hard surfaces, standing up from sitting position and standing for long time. The steroid and anesthetic injection to the sacrococcygeal, intercoccygeal joints and impar ganglions are the most commonly cited second line management option in the literatures for refractor cases. The coccygeal nerve blockade or radiofrequency ablation is also used for coccydynia especially for traumatic cases. The aim of the study is; to evaluate the efficacy of ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection in coccydynia and to investigate whether coccygeal nerve blockade has an additional contribution to this treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 24, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 13, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2024

Completed
Last Updated

September 26, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

December 24, 2022

Last Update Submit

September 24, 2024

Conditions

Keywords

CoccydyniaCoccygeal nerveUltrasonographyCoccyx

Outcome Measures

Primary Outcomes (3)

  • Change in pain severity of patients from baseline to each checkpoints

    Pain of the participants will be assessed by one of the most commonly used pain scale "numerical rating scale". It is numeric version of visual analog scale in which a patient selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing "pain as bad as you can imagine". Participant is asked to indicate rates of their pain on the day of presentation during palpation of coccyx, at the first sitting, sitting on soft and hard surface, standing up from sitting position, standing for long time, during defecation, sexual intercourse and menstrual cycle, and also 1 week, 4 weeks, 3 moths and 6 months after the injection for each. Participant is also asked to indicate rates of their pain one hour after the injection during sitting, standing up from sitting position and on palpation of coccyx.

    From pre-interventional time to post-interventional 1st hour, first week, 4th week, 3rd month, 6th moth

  • Change in pain-free sitting time of patients from baseline to each checkpoints

    Participant is asked to indicate pain-free sitting time as a minute on the day of presentation, and one hour, 1 week, 4 weeks, 3 moths and 6 months after the injection. Longer duration indicating better result.

    From pre-interventional time to post-interventional 1st hour, first week, 4th week, 3rd month, 6th moth

  • Pain according to NRS during injection

    the pain elicited by injection is asked to participants to determine effect of coccygeal nerve block after one hour of injection. The score ranges from 0 to 10, with 0 indicating "No Pain" and 10 "Worst Imaginable Pain

    1st hour

Secondary Outcomes (2)

  • Change the patient reported quality of life assessment from baseline to each checkpoints

    From pre-interventional time to post-interventional 4th week, 3rd month, 6th moth

  • Change the patient reported disability from baseline to each checkpoints

    From pre-interventional time to post-interventional 4th week, 3rd month, 6th moth

Study Arms (2)

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection

ACTIVE COMPARATOR

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection is applied to patients in this group

Procedure: Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection with coccygeal nerve block

ACTIVE COMPARATOR

Ultrasound-guided coccygeal nerve blockade is done before the application of ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection to patients in this group

Procedure: Ultrasound-guided coccygeal nerve blockProcedure: Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection after coccygeal nerve block

Interventions

Ultrasound guidance is used for correct visualization of injection site, and so obtained more successful results. Patients are placed in the prone position with a pillow under the abdomen to flatten the lumbar curvature. Lower extremities should be internally rotated while feet are inverted to help flatten the gluteal region. Injection site is cleaned thrice with povidone iodine %10 solution and covered with sterile drapes. Ultrasonography gel was applied on the probe and the probe was wrapped with a transparent thin sheath and cleaned with povidone iodine. Sterile gel is applied on the skin. The sacrococcygeal ligament, the sacrococcygeal and intercoccygeal joints were visualized. The sacrococcygeal and/or intercoccygeal joints were entered using the in-plane technique with a 23 gauge 6 cm long needle. When it was seen that the needle tip was inside the joint, 3 cc of 2% lidocaine + 1 cc betamethasone solution was injected.

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection

Patients are placed in the prone position with a pillow under the abdomen. Lower extremities are internally rotated while feet are inverted. Injection site and the probe are cleaned thrice with povidone iodine %10 solution. Sterile gel is applied. The prob was placed on coccygeal cornu and the coccygeal nerve was visualized superomedial to the CC in the subcutaneous tissue layer. Hydrodissection was made by administering 5 ml of 5% dextrose + 1 ml of 2% lidocaine via an in-plane approach with a 23 gauge 6 cm long needle, targeting the short axes of the bilateral coccygeal nerves.

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection with coccygeal nerve block

After the coccygeal nerve block, when the pain with palpation of the coccygeal region was reduced by at least 50%, the sacrococcygeal ligament, sacrococcygeal and intercoccygeal joints were visualized.The sacrococcygeal and/or intercoccygeal joints were entered using the in-plane technique with a 23 gauge 6 cm long needle. When the needle tip was inside the joint, 3 cc of 2% lidocaine + 1 cc betamethasone solution was injected.

Ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection with coccygeal nerve block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-65 years
  • Patients who have coccygeal pain and have not benefited from conservative treatment
  • Be able to understand enough Turkish to complete the outcome questionnaire
  • Patients whose informed consent was obtained for participation in the study

You may not qualify if:

  • Fibromyalgia
  • History of surgery for coccydynia
  • Pregnancy or breastfeeding
  • Inflammatory disease which effect the spine
  • Malignancy
  • Coagulation disorders
  • Infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Farih Sultan Mehmet Training and Research Hospital

Istanbul, Istanbul, 34752, Turkey (Türkiye)

Location

Related Publications (7)

  • Sencan S, Edipoglu IS, Ulku Demir FG, Yolcu G, Gunduz OH. Are steroids required in the treatment of ganglion impar blockade in chronic coccydynia? a prospective double-blinded clinical trial. Korean J Pain. 2019 Oct 1;32(4):301-306. doi: 10.3344/kjp.2019.32.4.301.

    PMID: 31569923BACKGROUND
  • Garg B, Ahuja K. Coccydynia-A comprehensive review on etiology, radiological features and management options. J Clin Orthop Trauma. 2021 Jan;12(1):123-129. doi: 10.1016/j.jcot.2020.09.025. Epub 2020 Sep 24.

    PMID: 33716437BACKGROUND
  • Mitra R, Cheung L, Perry P. Efficacy of fluoroscopically guided steroid injections in the management of coccydynia. Pain Physician. 2007 Nov;10(6):775-8.

    PMID: 17987101BACKGROUND
  • Datir A, Connell D. CT-guided injection for ganglion impar blockade: a radiological approach to the management of coccydynia. Clin Radiol. 2010 Jan;65(1):21-5. doi: 10.1016/j.crad.2009.08.007. Epub 2009 Oct 24.

    PMID: 20103417BACKGROUND
  • Woon JT, Stringer MD. Clinical anatomy of the coccyx: A systematic review. Clin Anat. 2012 Mar;25(2):158-67. doi: 10.1002/ca.21216. Epub 2011 Jul 7.

    PMID: 21739475BACKGROUND
  • Chen Y, Huang-Lionnet JHY, Cohen SP. Radiofrequency Ablation in Coccydynia: A Case Series and Comprehensive, Evidence-Based Review. Pain Med. 2017 Jun 1;18(6):1111-1130. doi: 10.1093/pm/pnw268.

    PMID: 28034983BACKGROUND
  • Wu WT, Hsu YC, Chang KV, Ozcakar L. Ultrasound Imaging and Ultrasound-Guided Injection of the Coccygeal Nerve for Coccydynia. Am J Phys Med Rehabil. 2022 Jul 1;101(7):e108-e109. doi: 10.1097/PHM.0000000000001987. Epub 2022 Feb 23. No abstract available.

    PMID: 35220319BACKGROUND

Study Officials

  • Feyza Unlu Ozkan

    Fatih Sultan Mehmet Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised, Double Blind Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 24, 2022

First Posted

January 13, 2023

Study Start

June 15, 2023

Primary Completion

December 28, 2023

Study Completion

June 18, 2024

Last Updated

September 26, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations